Biophysical characterization of rotavirus serotypes G1, G3 and G4

Human Vaccines

Volumn 6, Issue 5, 2010, Pages 390-398

  Esfandiary, Reza ^a   Yee, Luisa ^b   Ohtake, Satoshi ^b   Martin, Russell A ^b   Truong Le, Vu L ^b   Lechuga Ballesteros, David ^b   Moore, David S ^c   Joshi, Sangeeta B ^a   Russell Middaugh, C ^a  

^a UNIVERSITY OF KANSAS   (United States)

^b Aridis Pharmaceuticals LLC   (United States)

^c 343 Nichols Hall   (United States)

Author keywords

Circular dichroism; Dynamic light scattering; Electron microscopy; Empirical phase diagram; Fluorescence; Formulation; Rotavirus; Stability; Vaccine

Indexed keywords

ANTIGEN; ROTAVIRUS VACCINE;

ARTICLE; BIOLOGICAL ACTIVITY; CIRCULAR DICHROISM; FLUORESCENCE SPECTROSCOPY; HUMAN; LIGHT SCATTERING; NONHUMAN; PH MEASUREMENT; ROTAVIRUS; ROTAVIRUS INFECTION; SCREENING TEST; SEROTYPE; THERMOSTABILITY; VIRUS INFECTIVITY; VIRUS MORPHOLOGY;

EID: 77953727976     PISSN: 15548600     EISSN: 15548619     Source Type: Journal    
DOI: 10.4161/hv.6.5.10963     Document Type: Article

References (37)

1. Arias CF, Isa P, Guerrero CA, Mendez E, Zarate S, Lopez T, et al. Molecular biology of rotavirus cell entry. Archives of Medical Research 2002; 33:34-6.
2. Wilhelmi I, Roman E, Sanchez-Fauquier A. Viruses causing gastroenteritis. Clinical microbiology and infection 2003; 9:247-62.
3. Glass RI, Parashar UD, Bresee JS, Turcios R, Fischer TK, Widdowson MA, et al. Rotavirus vaccines: Current prospects and future challenges. Lancet 2006; 368:323-32.
4. Roberts L. Rotavirus vaccines' second chance. Science 2004; 305:1890-3.
5. Bernstein DI. Rotavirus overview. The Pediatric infectious disease Journal 2009; 28:50-3.
6. Matson DO. RotaShield: the ill-fated rhesus-human reassortant rotavirus vaccine. Pediatric annals 2006; 35:44-50.
7. Bines J. Intussusception and rotavirus vaccines. Vaccine 2006; 24:3772-6.
8. Bernstein DI. Live attenuated human rotavirus vaccine, Rotarix. Seminars in pediatric infectious diseases 2006; 17:188-94.
9. Offit PA, Clark HF. RotaTeq: A pentavalent bovine-human reassortant rotavirus vaccine. Pediatric annals 2006; 35:29-34.
10. Parashar UD, Glass RI. Progress toward rotavirus vaccines. Science 2006; 312:851-2.
11. Zaffran M. Vaccine transport and storage: environmental challenges. Developments in biological standardization 1996; 87:9-17.
12. Peetermans J. Factors affecting the stability of viral vaccines. Developments in biological standardization 1996; 87:97-101.
13. Milstien JA, Zaffran M. Thermostability of vaccines. World Health Organization: Geneva, Switzerland 1998.
14. Newman JF, Tirrell S, Ullman C, Piatti PG, Brown F. Stabilizing oral poliovaccine at high ambient temperatures. Developments in biological standardization 1996; 87:103-11.
15. Ausar SF, Espina M, Brock J, Thyagarayapuran N, Repetto R, Khandke L, Middaugh CR. High-throughput screening of stabilizers for respiratory syncytial virus: identification of stabilizers and their effects on the conformational thermostability of viral particles. Human Vaccines 2007; 3:94-103.
16. Burke CJ, Hsu TA, Volkin DB. Formulation, stability and delivery of live attenuated vaccines for human use. Critical reviews in therapeutic drug carrier systems 1999; 16:1-83.
17. Brandau DT, Jones LS, Wiethoff CM, Rexroad J, Middaugh CR. Thermal stability of vaccines. Journal of Pharmaceutical Sciences 2003; 92:218-31.
18. Chen D, Kristensen D. Opportunities and challenges of developing thermostable vaccines. Expert Revious of Vaccines 2009; 8:547-57.
19. Offit PA, Clark HF, Stroop WG, Twist EM, Plotkin SA. The cultivation of human rotavirus, strain 'Wa', to high titer in cell culture and characterization of the viral structural polypeptides. Journal of Virological Methods 1983; 7:29-40.
20. Hoshino Y, Kapikian AZ. Classification of rotavirus VP4 and VP7 serotypes. Archives of Virology (Suppl) 1996; 12:99-111.
21. Gentsch JR, Woods PA, Ramachandran M, Das BK, Leite JP, Alfieri A, et al. Review of G and P typing results from a global collection of rotavirus strains: implications for vaccine development. The Journal of infectious diseases 1996; 174:30-6.
22. Brown JC, Pusey PN. Photon Correlation Study of Polydisperse Samples of Polystyrene in Cyclohexane. Journal of Chemical Physics 1975; 62:1136-44.
23. Morrison ID, Grabowski EF, Herb CA. Improved techniques for particle size determination by quasi-elastic light scattering. Langmuir 1985; 1:496-501.
24. Pesavento JB, Crawford SE, Estes MK, Prasad BV. Rotavirus proteins: structure and assembly. Current topics in microbiology and immunology 2006; 309:189-219.
25. Shaw AL, Rothnagel R, Zeng CQ, Lawton JA, Ramig RF, Estes MK, Prasad BV. Rotavirus structure: interactions between the structural proteins. Archives of virology (Suppl) 1996; 12:21-7.
26. Lopez S, Arias CF. Multistep entry of rotavirus into cells: A Versaillesque dance. Trends in Microbiology 2004; 12:271-8.
27. Fields BN, Knipe DM, Howley PM, Griffin DE. Fields Virology. Philadelphia: Lippincott Williams&Wilkins 2001.
28. Meng Z, Birch C, Heath R, Gust I. Physicochemical stability and inactivation of human and simian rotaviruses. Applied and Environmental Microbiology 1987; 53:727-30.
29. Estes MK, Graham DY, Smith EM, Gerba CP. Rotavirus stability and inactivation. Journal of General Virology 1979; 43:403-9.
30. Weiss C, Clark HF. Rapid inactivation of rotaviruses by exposure to acid buffer or acidic gastric juice. Journal of General Virology 1985; 66:2725-30.
31. Welch AB, Thompson TL. Physicochemical characterization of a neonatal calf diarrhea virus. Canadian Journal of Comparative Medicine 1973; 37:295-301.
32. Peek LJ, Brandau DT, Jones LS, Joshi SB, Middaugh CR. A systematic approach to stabilizing EBA-175 RII-NG for use as a malaria vaccine. Vaccine 2006; 24:5839-51.
33. Kissmann JM, Ausar SF, Rudolph A, Braun C, Cape SP, Sievers RE, et al. Stabilization of measles virus for vaccine formulation. Human vaccines 2008; 4:350-9.
34. Ausar SF, Rexroad J, Frolov VG, Look JL, Konar N, Middaugh CR. Analysis of the thermal and pH stability of human respiratory syncytial virus. Molecular Pharmaceutics 2005; 2:491-9.
35. Ausar SF, Foubert TR, Hudson MH, Vedvick TS, Middaugh CR. Conformational stability and disassembly of Norwalk virus-like particles. Effect of pH and temperature. Journal of Biological Chemistry 2006; 281:19478-88.
36. Ruponen M, Braun CS, Middaugh CR. Biophysical characterization of polymeric and liposomal gene delivery systems using empirical phase diagrams. Journal of Pharmaceutical Sciences 2006; 95:2101-14.
37. Kueltzo LA, Ersoy B, Ralston JP, Middaugh CR. Derivative absorbance spectroscopy and protein phase diagrams as tools for comprehensive protein characterization: a bGCSF case study. Journal of Pharmaceutical Sciences 2003; 92:1805-20.